Board members and executives of Novo Nordisk reported transactions of company shares.

From GlobeNewswire: 2025-02-06 04:12:29

Novo Nordisk board members, executives, and associated persons reported transactions in Novo Nordisk shares in accordance with market abuse regulations. Details include the nature of the transactions, prices, volumes, and dates. The transactions involved both the transfer and sale of shares, with prices ranging from DKK 0.00 to DKK 621.01. The transactions were made outside trading venues such as Aquis Exchange Europe and CBOE Europe. The company is a global healthcare leader focused on defeating chronic diseases like diabetes, with products marketed in around 170 countries. For more information, visit the Novo Nordisk website.



Read more at GlobeNewswire: Trading in Novo Nordisk shares by board